Product NDC: | 50436-4234 |
Proprietary Name: | Bumetanide |
Non Proprietary Name: | Bumetanide |
Active Ingredient(s): | 2 mg/1 & nbsp; Bumetanide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50436-4234 |
Labeler Name: | Unit Dose Services |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074225 |
Marketing Category: | ANDA |
Start Marketing Date: | 20071016 |
Package NDC: | 50436-4234-1 |
Package Description: | 30 TABLET in 1 BOTTLE (50436-4234-1) |
NDC Code | 50436-4234-1 |
Proprietary Name | Bumetanide |
Package Description | 30 TABLET in 1 BOTTLE (50436-4234-1) |
Product NDC | 50436-4234 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Bumetanide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20071016 |
Marketing Category Name | ANDA |
Labeler Name | Unit Dose Services |
Substance Name | BUMETANIDE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |